Novel & Combination therapies in MDS Results in SF3B1, Cytidine Deaminase Inhibitors, Decitabine - 102305

Spotlight
Video

Novel & Combination therapies in MDS Results in SF3B1, Cytidine Deaminase Inhibitors, Decitabine

Loading........
Description: Marlise R. Luskin, MD, MSCE, Johns Hopkins University School of Medicine, discusses Novel & Combination therapies in MDS Results in SF3B1, Cytidine Deaminase Inhibitors, Decitabine at Imedex Great Debates 2018.
Shared By : hematologydebates
Posted on : 04/19/18
Added : 1 year ago